The Trump administration has quietly rehired FDA staff members who were previously let go in a sudden and confusing layoff process. This move comes after a wave of layoffs that left many employees uncertain about their future at the agency.
It remains unclear how many employees have been offered their jobs back, but there have been reports of broad rehirings in certain departments. For example, a group of employees who worked in the office responsible for reviewing surgical and infection control devices were all reinstated. Additionally, individuals working on digital health, AI-enabled technology, and other devices have also been brought back on board.
This development marks a significant shift in the administration’s approach to staffing at the FDA. The rehiring of these employees suggests a recognition of the importance of their roles in ensuring the safety and efficacy of medical devices and technologies.
For more details on this story, you can read the full article on STAT+. Stay tuned for further updates on this ongoing situation as more information becomes available.
To stay informed about the latest news and developments in the healthcare industry, be sure to subscribe to D.C. Diagnosis for regular updates. Remember to send any news or tips to sarah.owermohle@statnews.com. Thank you for reading, and have a great Tuesday!
